Facility Design and Engineering

Dec 08, 2017
By BioPharm International Editors
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
Dec 06, 2017
By BioPharm International Editors
The company will expand two of its Ohio facilities, investing approximately $145 million to support manufacturing and warehouse operations.
Dec 06, 2017
By BioPharm International Editors
The contract research, development, and manufacturing organization has expanded API aseptic manufacturing capacity at its Valladolid, Spain, facility.
Dec 01, 2017
By BioPharm International Editors
In a recently released statement, FDA Commissioner Scott Gottlieb warned of an amino acids supply shortage and gave an update on a saline supply shortage, both due to the impact of hurricanes on Puerto Rican manufacturing facilities.
Dec 01, 2017
By BioPharm International Editors
The company has opened a new California facility that, combined with its existing site in Foster City, CA, will quadruple its laboratory footprint for gene therapy products.
Nov 15, 2017
BioPharm International
The use of approved platform technologies can reduce the time and cost required to generate new vaccines.
Nov 15, 2017
BioPharm International
A new facility type integrates next-generation mobile cleanroom systems.
Nov 13, 2017
By BioPharm International Editors
The companies have established a joint laboratory to develop full continuous processing to manufacture high yields of monoclonal antibodies at reduced costs.
Nov 13, 2017
By BioPharm International Editors
Company completes first successful run of what is believed to be the largest synthesis-scale done for oligonucleotide APIs.
Oct 24, 2017
By BioPharm International Editors
The API manufacturer has announced that it has completed the expansion of large-scale manufacturing capabilities at its Charles City, Iowa site.
native1_300x100
lorem ipsum